Home - Products - Angiogenesis - EGFR - Cavutilide

Cavutilide

CAS No. 1276186-19-6

Cavutilide( —— )

Catalog No. M35602 CAS No. 1276186-19-6

Cavutilide has antiarrhythmic activity, inhibits hERG K(+) channels, and can be used to study heart failure and persistent atrial fibrillation.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	445	Get Quote
5MG	686	Get Quote
10MG	938	Get Quote
25MG	1398	Get Quote
50MG	1822	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Cavutilide
Note

Research use only, not for human use.
Brief Description

Cavutilide has antiarrhythmic activity, inhibits hERG K(+) channels, and can be used to study heart failure and persistent atrial fibrillation.
Description

Cavutilide, benzamide, is used as an antiarrhythmic, antiarythmique.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

EGFR
Recptor

EGFR
Research Area

——
Indication

——

Chemical Information

CAS Number

1276186-19-6
Formula Weight

399.458
Molecular Formula

C22H26FN3O3
Purity

>98% (HPLC)
Solubility

——
SMILES

CCN1CCC(CC(c(cc2)ccc2F)NC(c(cc2)ccc2[N+]([O-])=O)=O)CC1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. WHO Drug Information, Vol. 36, No. 2, 2022.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Cavutilide

Cavutilide has antiarrhythmic activity, inhibits hERG K(+) channels, and can be used to study heart failure and persistent atrial fibrillation.
WHI-P258

WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.
Sunvozertinib

Sunvozertinib (DZD9008) is a potent ErbBs and BTK inhibitor, with inhibitory effects on EGFR, Her2, and mutant epidermal growth factor.

Sign In Join Free